North America and Europe Dominate Oncology Clinical Trials...

добавлена новая статья Главная

2025-10-28 12:22:05 -

North America and Europe Dominate Oncology Clinical Trials Landscape Amid Robust R&D and Regulatory Support

The oncology clinical trials market was valued at USD 14.21 billion in 2024 and is projected to expand at a CAGR of 5.17% between 2025 and 2034. Growth is increasingly defined by segmentation performance across trial phase (Phase I, II, III, IV), study design (interventional, observational), tumour indication (lung, breast, colorectal, hematologic) and sponsor type (pharma/biotech, academic,...

0 Комментарии 0 Поделились 65 Просмотры 0 предпросмотр